KEGG   Nannospalax galili (Upper Galilee mountains blind mole rat): 103744668
Entry
103744668         CDS       T03372                                 
Name
(RefSeq) caspase-3-like
  KO
K02187  caspase 3 [EC:3.4.22.56]
Organism
ngi  Nannospalax galili (Upper Galilee mountains blind mole rat)
Pathway
ngi01524  Platinum drug resistance
ngi04010  MAPK signaling pathway
ngi04115  p53 signaling pathway
ngi04148  Efferocytosis
ngi04210  Apoptosis
ngi04215  Apoptosis - multiple species
ngi04623  Cytosolic DNA-sensing pathway
ngi04650  Natural killer cell mediated cytotoxicity
ngi04657  IL-17 signaling pathway
ngi04668  TNF signaling pathway
ngi04726  Serotonergic synapse
ngi04932  Non-alcoholic fatty liver disease
ngi04933  AGE-RAGE signaling pathway in diabetic complications
ngi04936  Alcoholic liver disease
ngi05010  Alzheimer disease
ngi05012  Parkinson disease
ngi05014  Amyotrophic lateral sclerosis
ngi05016  Huntington disease
ngi05020  Prion disease
ngi05022  Pathways of neurodegeneration - multiple diseases
ngi05132  Salmonella infection
ngi05133  Pertussis
ngi05134  Legionellosis
ngi05145  Toxoplasmosis
ngi05146  Amoebiasis
ngi05152  Tuberculosis
ngi05160  Hepatitis C
ngi05161  Hepatitis B
ngi05162  Measles
ngi05163  Human cytomegalovirus infection
ngi05164  Influenza A
ngi05165  Human papillomavirus infection
ngi05167  Kaposi sarcoma-associated herpesvirus infection
ngi05168  Herpes simplex virus 1 infection
ngi05169  Epstein-Barr virus infection
ngi05170  Human immunodeficiency virus 1 infection
ngi05200  Pathways in cancer
ngi05203  Viral carcinogenesis
ngi05205  Proteoglycans in cancer
ngi05206  MicroRNAs in cancer
ngi05210  Colorectal cancer
ngi05222  Small cell lung cancer
ngi05416  Viral myocarditis
ngi05417  Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:ngi00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    103744668
   04668 TNF signaling pathway
    103744668
 09140 Cellular Processes
  09141 Transport and catabolism
   04148 Efferocytosis
    103744668
  09143 Cell growth and death
   04210 Apoptosis
    103744668
   04215 Apoptosis - multiple species
    103744668
   04115 p53 signaling pathway
    103744668
 09150 Organismal Systems
  09151 Immune system
   04623 Cytosolic DNA-sensing pathway
    103744668
   04650 Natural killer cell mediated cytotoxicity
    103744668
   04657 IL-17 signaling pathway
    103744668
  09156 Nervous system
   04726 Serotonergic synapse
    103744668
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    103744668
   05206 MicroRNAs in cancer
    103744668
   05205 Proteoglycans in cancer
    103744668
   05203 Viral carcinogenesis
    103744668
  09162 Cancer: specific types
   05210 Colorectal cancer
    103744668
   05222 Small cell lung cancer
    103744668
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    103744668
   05161 Hepatitis B
    103744668
   05160 Hepatitis C
    103744668
   05164 Influenza A
    103744668
   05162 Measles
    103744668
   05168 Herpes simplex virus 1 infection
    103744668
   05163 Human cytomegalovirus infection
    103744668
   05167 Kaposi sarcoma-associated herpesvirus infection
    103744668
   05169 Epstein-Barr virus infection
    103744668
   05165 Human papillomavirus infection
    103744668
  09171 Infectious disease: bacterial
   05132 Salmonella infection
    103744668
   05133 Pertussis
    103744668
   05134 Legionellosis
    103744668
   05152 Tuberculosis
    103744668
  09174 Infectious disease: parasitic
   05146 Amoebiasis
    103744668
   05145 Toxoplasmosis
    103744668
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    103744668
   05012 Parkinson disease
    103744668
   05014 Amyotrophic lateral sclerosis
    103744668
   05016 Huntington disease
    103744668
   05020 Prion disease
    103744668
   05022 Pathways of neurodegeneration - multiple diseases
    103744668
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    103744668
   05416 Viral myocarditis
    103744668
  09167 Endocrine and metabolic disease
   04936 Alcoholic liver disease
    103744668
   04932 Non-alcoholic fatty liver disease
    103744668
   04933 AGE-RAGE signaling pathway in diabetic complications
    103744668
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    103744668
 09180 Brite Hierarchies
  09181 Protein families: metabolism
   01002 Peptidases and inhibitors [BR:ngi01002]
    103744668
Enzymes [BR:ngi01000]
 3. Hydrolases
  3.4  Acting on peptide bonds (peptidases)
   3.4.22  Cysteine endopeptidases
    3.4.22.56  caspase-3
     103744668
Peptidases and inhibitors [BR:ngi01002]
 Cysteine peptidases
  Family C14: caspase family
   103744668
SSDB
Motif
Pfam: Peptidase_C14 NFD4_C
Other DBs
NCBI-GeneID: 103744668
NCBI-ProteinID: XP_017656954
LinkDB
Position
Un
AA seq 235 aa
MDSGISLDNSYKIDYPKTGLCIIINNFHKSIRMSPQSGTDVGSANLRETFMNLKYEVRNK
NDLTHEEILELLHNVSQEDHNKRGSFVCGSLSHGEEGKNFGTNGSVDLKKLTNFFRGDYC
QTLNWVFLTGKPRLFIIQACQGTALDCGIETDSGTHEVVSQKIPVEADFLYAYSTALGYY
SQRNSDGSRFIQSLCALLNEYSHKLEFVHILIHVNRKVATQFESFSFDSTFHAKK
NT seq 708 nt   +upstreamnt  +downstreamnt
atggactctggaatatccttggacaatagttacaaaatcgattatcctaaaacaggttta
tgtataataattaataactttcataaaagcatcaggatgtcacctcaatctggtacagat
gtaggctcagccaacctcagagaaacattcatgaacttgaagtatgaagtcaggaataaa
aatgatcttacccatgaagaaattttggaattgttacacaatgtttctcaagaagatcac
aacaagaggggcagctttgtttgtggaagtctaagccatggtgaggaaggaaaaaatttt
ggaacaaatggatctgttgacctgaaaaaattaactaatttcttcagaggagattattgc
caaactctgaactgggtttttctaacgggaaaacccagacttttcattattcaggcctgc
cagggtacagcgctagactgtggtattgagacagacagtggcactcatgaggtagtgagc
cagaagatacctgtggaggctgacttcctgtacgcatactccacagcactgggttactac
tcccagagaaattcagatggatccaggttcatccagtcactttgcgctctgctgaacgaa
tactcacacaagcttgagtttgtgcacattcttattcatgttaaccggaaggtagccaca
caatttgagtccttttcttttgactccacttttcatgcaaagaaatag

DBGET integrated database retrieval system